Literature DB >> 17255416

Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging.

Antonio C A Westphalen1, Aliya Qayyum, Benjamin M Yeh, Raphael B Merriman, Julie A Lee, Amit Lamba, Ying Lu, Fergus V Coakley.   

Abstract

PURPOSE: To retrospectively determine the effect of liver iron deposition on the evaluation of liver fat by using opposed-phase magnetic resonance (MR) imaging.
MATERIALS AND METHODS: Committee on Human Research approval was obtained, and compliance with HIPAA regulations was observed. Patient consent was waived by the committee. Thirty-eight patients with cirrhosis (30 men, eight women; mean age, 58 years; range, 34-76 years) who underwent abdominal MR imaging and had contemporaneous liver biopsy were retrospectively identified. Two radiologists independently quantified liver fat according to the relative loss of signal intensity and compared this loss on opposed-phase and in-phase T1-weighted gradient-echo images. Liver fat percentage and presence of iron deposition were independently recorded by a pathologist. Generalized linear models, which included a mixed-random effects model, were used to determine the effect of iron deposition on the Spearman correlation coefficient for relative signal intensity loss versus histopathologically determined fat percentage.
RESULTS: Liver iron deposition was found in 25 of 38 patients. Liver fat percentage (mean, 3%; range, 0%-25%) was identified histopathologically in 14 of 38 patients and in nine of 25 patients with iron deposition. For both readers, relative signal intensity loss at opposed-phase imaging was closely and significantly correlated (P < .05) with histopathologically determined liver fat percentage in patients without iron deposition (r = 0.7 for reader 1, r = 0.6 for reader 2), but no such correlation was found in patients with iron deposition (r = 0.1 for reader 1, r = -0.31 for reader 2; P > .05).
CONCLUSION: Signal intensity loss on in-phase images caused by the presence of liver iron is a potential pitfall in the determination of liver fat percentage at opposed-phase MR imaging in chronic liver disease. (c) RSNA, 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255416     DOI: 10.1148/radiol.2422052024

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  47 in total

1.  Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.

Authors:  Hong Koh; Seung Kim; Myung-Joon Kim; Hyun Gi Kim; Hyun Joo Shin; Mi-Jung Lee
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

2.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

3.  Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL.

Authors:  Hyeonjin Kim; Sara E Taksali; Sylvie Dufour; Douglas Befroy; T Robin Goodman; Kitt Falk Petersen; Gerald I Shulman; Sonia Caprio; R Todd Constable
Journal:  Magn Reson Med       Date:  2008-03       Impact factor: 4.668

4.  Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy.

Authors:  Boris Guiu; Romaric Loffroy; Jean-Michel Petit; Serge Aho; Douraied Ben Salem; David Masson; Patrick Hillon; Jean-Pierre Cercueil; Denis Krause
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

Review 5.  Liver fat content determined by magnetic resonance imaging and spectroscopy.

Authors:  Fabian Springer; Jürgen Machann; Claus D Claussen; Fritz Schick; Nina F Schwenzer
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

6.  Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.

Authors:  Jens-Peter Kühn; Diego Hernando; Birger Mensel; Paul C Krüger; Till Ittermann; Julia Mayerle; Norbert Hosten; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

7.  Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?

Authors:  Aliya Qayyum; Daryl M Chen; Richard S Breiman; Antonio C Westphalen; Benjamin M Yeh; Kirk D Jones; Ying Lu; Fergus V Coakley; Peter W Callen
Journal:  Clin Imaging       Date:  2009 Mar-Apr       Impact factor: 1.605

8.  MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.

Authors:  Guido Ligabue; Giulia Besutti; Riccardo Scaglioni; Chiara Stentarelli; Giovanni Guaraldi
Journal:  Quant Imaging Med Surg       Date:  2013-08

Review 9.  Magnetic Resonance Elastography of Liver: Current Update.

Authors:  Safa Hoodeshenas; Meng Yin; Sudhakar Kundapur Venkatesh
Journal:  Top Magn Reson Imaging       Date:  2018-10

10.  Reproducible MRI measurement of adipose tissue volumes in genetic and dietary rodent obesity models.

Authors:  David H Johnson; Chris A Flask; Paul R Ernsberger; Wilbur C K Wong; David L Wilson
Journal:  J Magn Reson Imaging       Date:  2008-10       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.